Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing.

Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing. J Hematol Oncol. 2013 Oct 22; 6:79.

View in: PubMed